Systemic Juvenile Idiopathic Arthritis (SJIA):治療薬市場動向2014(市場規模、グローバルAPIメーカー、第Ⅲ相試験)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIIR2014474)
◆英語タイトル: Systemic Juvenile Idiopathic Arthritis (SJIA) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DIIR2014474
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:75以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,000 ⇒換算¥220,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD6,000 ⇒換算¥660,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Systemic Juvenile Idiopathic Arthritis (SJIA):治療薬市場動向2014(市場規模、グローバルAPIメーカー、第Ⅲ相試験)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s, “ Systemic Juvenile Idiopathic Arthritis (SJIA)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclusivity details of all the drugs across the indication.

Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


• A snapshot of the global Market therapeutics scenario for Systemic Juvenile Idiopathic Arthritis (SJIA).
• A review of the marketed products under prescription for Systemic Juvenile Idiopathic Arthritis (SJIA), regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Systemic Juvenile Idiopathic Arthritis (SJIA) with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Systemic Juvenile Idiopathic Arthritis (SJIA) drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Systemic Juvenile Idiopathic Arthritis (SJIA) drugs.
• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Systemic Juvenile Idiopathic Arthritis (SJIA) drugs.
• Coverage of Systemic Juvenile Idiopathic Arthritis (SJIA) Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure from 2011-2015.

• Evaluate the marketing status and exclusivity details of Systemic Juvenile Idiopathic Arthritis (SJIA) key products to exploit opportunities for generic drug development opportunities.
• Identify and understand important and diverse types of therapeutics under Phase III development for Systemic Juvenile Idiopathic Arthritis (SJIA).
• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Systemic Juvenile Idiopathic Arthritis (SJIA).
• API intelligence over marketed drugs for Systemic Juvenile Idiopathic Arthritis (SJIA) and gaining primary intelligence over active ingredients manufacturers across the globe.
• API intelligence over leading Phase III pipeline drugs.
• Develop and designstrategies by identifying the API manufacturers for Phase III pipeline products to enhance and expand business potential and scope.
• Understanding the scope of the Phase III Drugs with nil regulatory filings.
• Understanding the chemical route of synthesis of approved drugs for Systemic Juvenile Idiopathic Arthritis (SJIA).
• Uncovering opportunities in the rapidly growing the US markets.

*** レポート目次(コンテンツ)***

• Indication Overview
• Marketed Drugs Assessment
• Marketed Details of Drugs by Application Type
• Marketed Details of Drugs (NDA) by Marketing Status
• Marketed Details of Drugs by Patent Expiration Timeline
• The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
• The API Manufacturers by the United States Drug Master File (US DMF) Status
• The API Manufacturers by the US DMF Status (Drug Specific)
• The Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
• The API Manufacturers by the US DMF Status (Drug Specific)
• Drugs Market Data and Forecasted Sales Figures (2011-2015)
• Marketed Drugs Information
• Drugs Description
• Route of Synthesis
• Global Active Pharmaceutical Manufacturers
• Approval Status
• Patent and Exclusivity Details
• Company Overview
• Phase III Drugs Information
• Phase III Drugs Description
• The United States Drug Master Filings (US DMF)
• Discontinued Drugs Information

Systemic Juvenile Idiopathic Arthritis (SJIA) Therapeutic Market, US, Marketed Drugs by Application Type, 2014
Systemic Juvenile Idiopathic Arthritis (SJIA) Therapeutic Market, US, Marketed Drugs by Marketing Status, 2014
Systemic Juvenile Idiopathic Arthritis (SJIA) Therapeutic Market, US, (Year), 2014
Systemic Juvenile Idiopathic Arthritis (SJIA) Marketed Drugs, API Manufacturers by US DMF Status, 2014
Systemic Juvenile Idiopathic Arthritis (SJIA) Marketed Drugs, US DMF Status Drug Specific (Number), 2014
Systemic Juvenile Idiopathic Arthritis (SJIA) Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2014
Systemic Juvenile Idiopathic Arthritis (SJIA) Therapeutic Market, Global Sales (in million USD), 2014
Systemic Juvenile Idiopathic Arthritis (SJIA) Marketed Drugs, API Manufacturers, Global, 2014
Systemic Juvenile Idiopathic Arthritis (SJIA) Phase III Pipeline Drugs, United States Drug Master File (DMF), 2014
Discontinued Drugs for Systemic Juvenile Idiopathic Arthritis (SJIA), 2014

Systemic Juvenile Idiopathic Arthritis (SJIA) Therapeutic Market, US, Marketed Drugs by Application Type (%), 2014
Systemic Juvenile Idiopathic Arthritis (SJIA) Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2014
Systemic Juvenile Idiopathic Arthritis (SJIA) Therapeutic Market, US, (Year), 2014
Systemic Juvenile Idiopathic Arthritis (SJIA) Marketed Drugs, API Manufacturers by US DMF Status (%), 2014
Systemic Juvenile Idiopathic Arthritis (SJIA) Marketed Drugs, US DMF Status Drug Specific (Number), 2014
Systemic Juvenile Idiopathic Arthritis (SJIA) Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2014
Systemic Juvenile Idiopathic Arthritis (SJIA) Therapeutic Market, Global Sales (in million USD), 2014
Systemic Juvenile Idiopathic Arthritis (SJIA) Marketed Drugs, Patent/Exclusivity Expiry (Year), 2014

*** 掲載企業 ***

Hoffmann-La Roche Inc.
Abbott Laboratories

*** レポートのキーワード ***

Systemic Juvenile Idiopathic Arthritis (SJIA)、医薬品、治療薬、規模、販売量、医薬品有効成分(API)メーカー、第Ⅲ相試験、製薬

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • オレオケミカル脂肪酸の世界市場2016
    The Global Oleochemical Fatty Acids Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Oleochemical Fatty Acids industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry …
  • 浮体式液化天然ガス(FLNG)の世界市場
    This latest report by business intelligence provider visiongain assesses that Floating Liquefied Natural Gas spending will reach $9.6bn in 2018. The floating liquefied natural gas (FLNG) market is developing quicklyand the number of countries ordering FSRUs expanding. Though the impact of lower oil …
  • シンガポールのタービン市場(規模、トレンド、予測~2018年)
    The industry data report Turbine Market in Singapore to 2018 - Market Size, Trends, and Forecasts offers the most up-to-date market data on the actual market situation, trends and future outlook for turbines in Singapore. This research includes historic market data from 2007 to 2013 and forecasts un …
  • オフグリッドエネルギー貯蔵システムの世界市場2016
    The Global Off-grid Energy Storage System Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Off-grid Energy Storage System industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications …
  • CytRx Corporation :企業製品パイプライン分析2013(ヘルスケア市場レポート)
    CytRx Corporation – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “CytRx Corporation - Product Pipeline Review - 2013” provides data on the CytRx Corporation’s research and development focus. The report includes information on current developmental pipeline, c …
  • 道路洗浄機の世界及び中国市場 2018年
    The 'Global and Chinese Road Washer Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Road Washer industry with a focus on the Chinese market. The report provides key statistics on the market status of the Road Washer manufacturers an …
  • 世界の緑茶抽出物市場2016
    2016 Global Green Tea Extract Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Green Tea Extract industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and Chin …
  • アルキルナフタレンスルホン酸塩ナトリウムの世界市場:販売動向2017
    Notes:Sales, means the sales volume of Sodium Alkyl Naphthalene Sulfonate Revenue, means the sales value of Sodium Alkyl Naphthalene Sulfonate This report studies sales (consumption) of Sodium Alkyl Naphthalene Sulfonate in Global market, especially in United States, China, Europe and Japan, focuses …
  • ベトナムの船舶用推進エンジン市場(~2020):市場規模、動向、予測
    The report Marine Propulsion Engine Market in Vietnam to 2020 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for marine propulsion engines in Vietnam. The research includes historic data from 2009 to 2015 and fore …
  • 半導体製造材料の世界市場2016
    The Global Semiconductor Fabrication Material Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Semiconductor Fabrication Material industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, appli …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIIR2014474 )"Systemic Juvenile Idiopathic Arthritis (SJIA):治療薬市場動向2014(市場規模、グローバルAPIメーカー、第Ⅲ相試験)" (英文: Systemic Juvenile Idiopathic Arthritis (SJIA) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。